(VHT) Vanguard Health Care - Ratings and Ratios
Pharmaceuticals, Biotechnology, Healthcare, Medical, Equipment
Description: VHT Vanguard Health Care
The Vanguard Health Care Index Fund ETF Shares (VHT) is an exchange-traded fund that tracks the performance of the healthcare sector in the US stock market, covering large, mid-size, and small-cap companies classified under the Global Industry Classification Standard (GICS). By replicating the target index, the fund aims to invest in the constituent stocks in proportion to their weighting, providing broad exposure to the US healthcare sector.
Key performance indicators (KPIs) for VHT include its ability to provide diversified exposure to the healthcare sector, with a portfolio comprising a range of companies across various sub-sectors, such as pharmaceuticals, biotechnology, and healthcare equipment. The funds tracking error, expense ratio, and trading volume are also important metrics to evaluate its performance. With an AUM of $15.34 billion, VHT is a sizable and liquid ETF, making it an attractive option for investors seeking to gain exposure to the US healthcare sector.
From a quantitative perspective, VHTs performance can be evaluated using metrics such as its Sharpe ratio, beta, and alpha relative to its benchmark index. The funds sector allocation, market capitalization distribution, and stock holdings are also important factors to consider when assessing its investment profile. As a passively managed ETF, VHTs low expense ratio and tax efficiency are additional benefits that can contribute to its overall performance.
Additional Sources for VHT ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
VHT ETF Overview
Market Cap in USD | 15,344m |
Category | Health |
TER | 0.10% |
IPO / Inception | 2004-01-26 |
VHT ETF Ratings
Growth Rating | 18.5 |
Fundamental | - |
Dividend Rating | 56.1 |
Rel. Strength | -23.2 |
Analysts | - |
Fair Price Momentum | 218.51 USD |
Fair Price DCF | - |
VHT Dividends
Dividend Yield 12m | 1.58% |
Yield on Cost 5y | 2.08% |
Annual Growth 5y | 7.36% |
Payout Consistency | 96.0% |
Payout Ratio | % |
VHT Growth Ratios
Growth Correlation 3m | 36.5% |
Growth Correlation 12m | -84.3% |
Growth Correlation 5y | 75.8% |
CAGR 5y | 4.74% |
CAGR/Max DD 5y | 0.27 |
Sharpe Ratio 12m | -0.93 |
Alpha | -21.58 |
Beta | 0.553 |
Volatility | 14.78% |
Current Volume | 394.9k |
Average Volume 20d | 297k |
Stop Loss | 234.2 (-3%) |
As of August 01, 2025, the stock is trading at USD 241.48 with a total of 394,877 shares traded.
Over the past week, the price has changed by -3.46%, over one month by -2.76%, over three months by -5.26% and over the past year by -10.75%.
Neither. Based on ValueRay´s Analyses, Vanguard Health Care is currently (August 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 18.45 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of VHT is around 218.51 USD . This means that VHT is currently overvalued and has a potential downside of -9.51%.
Vanguard Health Care has no consensus analysts rating.
According to our own proprietary Forecast Model, VHT Vanguard Health Care will be worth about 248.3 in August 2026. The stock is currently trading at 241.48. This means that the stock has a potential upside of +2.82%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 248.3 | 2.8% |